Skip to main navigation Skip to search Skip to main content

RECOVERY OF ADRENAL FUNCTION AFTER TREATMENT OF ADRENOCORTICAL CARCINOMA WITH o,p’‐DDD

  • F. GREIG
  • , S. E. OBERFIELD
  • , L. S. LEVINE
  • , F. GHAVIMI
  • , S. PANG
  • , M. I. NEW

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

The adrenolytic agent, 2,2‐bis [2‐chlorophenyl‐4‐chlorophenyl] 1,1 dichloroethane (o.p'‐DDD), was used over a 20‐month period following surgery in a 2 3/12‐year‐old girl for treatment of adrenocortical carcinoma. The child remained free of disease and was maintained on glucocorticoid and mineralo‐corticoid supplements for 7 years. Hormonal evaluation was undertaken at 9 9/12 years of age to determine remaining adrenal steroidogenic capacity. Following discontinuation of both hydrocortisone and 9α‐fludrocortisone, she remained stable and asymptomatic. Immediately after discontinuing 9α‐fludrocortisone, the adrenal glomerulosa was able to respond to stimulation by the renin‐angiotensin system as shown by the ability to achieve renal sodium conservation on a restricted sodium intake (< 10 mEq/d for 5 d). The response of the adrenal fasciculata to ACTH stimulation showed a slower recovery. Baseline levels of cortisol were in the low normal range, but there was no increase in plasma cortisol or urinary 17‐hydroxysteroids following stimulation with ACTH. The responses of cortisol, deoxycorticosterone, and corticosterone to ACTH stimulation gradually improved to achieve normal stimulated levels 18 months after stopping medications. Serum testosterone and δ4‐androstenedione were initially increased for level of puberty, while levels of dehydroepian‐drosterone were prepubertal. Testosterone and δ4‐androstenedione did not suppress with dexamethasone (2 mg/d for 2 d; 4 mg/d for 2 d), and dehydroepiandrosterone decreased only slightly. However, administration of norethindrone (Norlutin) (10 mg orally, three times a day for 3 d) resulted in suppression while human chorionic gonadotrophin (hCG; 5000 U i.m. daily for 3 d) produced stimulation of testosterone, δ4‐androstenedione and dehydroepiandrosterone. Thus the androgens were felt be predominantly of ovarian origin. Dehydroepiandrosterone rose to low normal levels by 18 months after discontiution of hydrocotesone. We thus demonstrate for the first time that both the adrenal glomerulosa and fasiculata have the capacity to recover normal function following treatment with o,p'‐DDD. Further, we suggest that early exposure to excess adrenal androgens may result in mild alteration of gonadal function.

Original languageEnglish
Pages (from-to)389-399
Number of pages11
JournalClinical Endocrinology
Volume20
Issue number4
DOIs
StatePublished - Apr 1984
Externally publishedYes

Fingerprint

Dive into the research topics of 'RECOVERY OF ADRENAL FUNCTION AFTER TREATMENT OF ADRENOCORTICAL CARCINOMA WITH o,p’‐DDD'. Together they form a unique fingerprint.

Cite this